Lasa Supergenerics

Lasa Supergenerics is an India-based public pharmaceutical manufacturer focused primarily on veterinary and selected human healthcare active pharmaceutical ingredients. The company operates as a vertically integrated manufacturer spanning research, process development, backward integration, manufacturing, and marketing, with a particular emphasis on anthelmintic and veterinary API products. Its product portfolio includes multiple commercial small-molecule APIs such as fenbendazole, albendazole, riclabendazole, rafoxanide, oxfendazole, closantel, nitroxynil, oxyclozanide, halquinol, and ornidazole, along with animal feed ingredients and reagents for therapeutic use. Lasa positions its technical strength around catalyst chemistry and domestic manufacturing scale in India. The business appears to be commercially focused rather than a clinical-stage drug developer, and there is no evidence of a proprietary therapeutic pipeline in human biotech development.